mRNA cancer drug shows breakthrough in melanoma trial

August 19-21, 2026 Merck Moderna Melanoma mRNA therapy

Between August 19-21, 2026, US drugmakers Merck and Moderna announced that a personalized mRNA cancer treatment reduced melanoma recurrence in a late-stage trial. The breakthrough builds on mRNA technology from Covid-19 vaccines.

3 reports · 1 independentinternational · other

Claim audit

No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.

All coverage

‘Breakthrough’ mRNA cancer drug curbs melanoma in large trial

rss:straitstimes-worldinternational41d ago wire ×3 kagi ↗

The drug is based on the same messenger RNA (mRNA) technology behind Covid-19 vaccines.

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

stream:bsky-jetstreamother40d ago echo kagi ↗

this outlet adds: drugmakers, merck, moderna, wednesday, personalized, treatment, shown, success

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

rss:france24international39d ago echo kagi ↗

this outlet adds: drugmakers, merck, moderna, wednesday, personalised, treatment, shown, success